30 related articles for article (PubMed ID: 9489954)
1. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.
Suzuki T; Takano Y
Jpn J Cancer Res; 1993 Oct; 84(10):1072-7. PubMed ID: 7901190
[TBL] [Abstract][Full Text] [Related]
2. Long-term analysis to objectify the tumour grading by means of automated microscopic image analysis of the nucleolar organizer regions (AgNORs) in the case of breast carcinoma.
Winzer KJ; Bellach J; Hufnagl P
Diagn Pathol; 2013 Apr; 8():56. PubMed ID: 23566354
[TBL] [Abstract][Full Text] [Related]
3. Measuring proliferation in breast cancer: practicalities and applications.
Beresford MJ; Wilson GD; Makris A
Breast Cancer Res; 2006; 8(6):216. PubMed ID: 17164010
[TBL] [Abstract][Full Text] [Related]
4. Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?
Elzagheid A; Kuopio T; Pyrhönen S; Collan Y
Diagn Pathol; 2006 Nov; 1():41. PubMed ID: 17092354
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
6. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
7. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells].
Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
Vopr Onkol; 1998; 44(3):316-24. PubMed ID: 9695779
[TBL] [Abstract][Full Text] [Related]
9. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
10. Tumor proliferative fraction in infiltrating duct carcinoma.
Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
[TBL] [Abstract][Full Text] [Related]
11. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
Zaczek M
Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
[TBL] [Abstract][Full Text] [Related]
12. [Importance of AgNOR analysis in malignant tumors].
Martin H
Zentralbl Pathol; 1994 Mar; 140(1):15-22. PubMed ID: 8204559
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
